Bioethics Blogs

An Alternative Point of View: The Societal Benefits of the Amgen v. Regeneron Injunction

Special Guest Post by Beau H. Miller, Jefferies This article was originally published as part of research issued by the Jefferies Biotechnology Equity Research group. Since the Amgen v. Regeneron ruling that resulted in Judge Robinson of the District Court … Continue reading

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.